Laos

The Asian Medtech Associations Regulatory Networking discussions this month centered on strategies to control COVID-19 locally and the activities of the ASEANMed industry association. This editorial feature is hosted by Medtech Insight, along with the ARQon Asia Regulatory and Quality Consultancy and the Asia Regulatory Professional Association. This is the second of two articles on the discussions.

Thailand is on the cusp of integrating new medtech adverse-event reporting guidelines, Malaysia is making good headway with its new regulatory system, and the Philippines is moving ahead with plans for a medical device fees schedule. Myanmar and Brunei are among other ASEAN member states included in this latest Asian regulatory update from Medtech Insight.